Stallergenes Greer, a global leader in allergy therapeutics, today announced that the Board of Directors has appointed Andreas Amrein as Chief Executive Officer, with effect from April 1 ...

The city said it will seek follow-up questions on the proposals, which included plans for a hotel at the site.

Volkswagen AG is prepared to support the ramp-up of Europe’s defense capacity as the region’s decades-long military alliance ...

Article continues below But there is a county where tourists are welcomed with open arms. Morocco has established itself as one of the fastest growing holiday destinations in the world - and among ...

In an interview with Welt am Sonntag, Rutte stated that NATO members need to spend more on ensuring their own security. "But we also need to quickly ramp up our defence production on both sides of the ...

Everton have confirmed Angus Kinnear as their new chief executive officer, with the former Leeds United CEO set to take up his role on June 1. The Toffees continue their restructuring following ...

Bollywood actor Ajay Devgn, renowned for his immense contributions to Indian cinema, continues to push boundaries with his industry expertise. Following the success of NY VFXWaala and his ...

The chief executive of Canoo Inc. has formed a company to acquire the assets of the bankrupt electric vehicle manufacturer for $4 million. Known as WHS Energy Solutions, the company founded by ...

Chief commercial and communications officer Richard Kenyon will also be leaving the club, with new appointments in the executive leadership team to be announced in due course. Everton said they ...

Geoffroy Sardin joined PULLUP Entertainment in January 2024 and is now entrusted, as Chief Executive Officer and corporate officer, with the operational responsibilities previously held by May 2023.

PARIS, FRANCE – March 6, 2025 – The Board of Directors of PULLUP Entertainment (FR0012419307 - ALPUL) announces the appointment of Geoffroy Sardin as a corporate officer, Chief Executive ...

“We are pleased to report the positive outcome of our End-of-Phase 2 meeting with the FDA,” said George Lasezkay, PharmD, JD, President and Chief Executive Officer. “With a positive safety ...